Skip to main content

Avanos Medical, Inc.

AVNSDelisted
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001606498

Avanos Medical, Inc. was delisted in 2026; its insiders filed their last Form 4 on Jul 28, 2026; 286 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Avanos Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Avanos Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Avanos Medical, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Delgado SigfridoSVP, Operations0Jul 28, 20263
Galovan Scott MichaelSVP, Chief Financial Officer0Jul 28, 20265
Pacitti DavidChief Executive Officer0Jul 28, 20263
Shimer Julie AnnDirector0Jul 28, 20262
Oleary Patrick JDirector0Jul 28, 20262
Franchini Indrani LallDirector0Jul 28, 20262
Egbuonu-Davis LisaDirector0Jul 28, 20262
Blackford GaryDirector0Jul 28, 20262
Hurley John JosephPrincipal Accounting Officer13,592Mar 17, 20263
Holbrook KerrSVP, Chief Commercial Officer83,860Nov 19, 20251
Greiner MichaelFormer Interim CEO200,019May 14, 20250
James MojiradeSVP, General Counsel104,518Apr 24, 20250
Woody Joseph FralinOther: Former Chief Executive Officer402,776Mar 10, 20250
Varshney SudhakarSVP, Global Supply Chain30,197Mar 7, 20240
Byrnes John PDirector49,618Jan 4, 20240
Sarker Arjun RanjanSenior VP, International26,761Mar 23, 20230
Haydon William DavidSVP, GM Pain Franchise28,443Mar 7, 20230
Ball David EdwardSVP - Global Supply Chain10,636Sep 8, 20220
Sainz MariaDirector33,396Jan 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 19, 2025 (view filing)Nov 181 dayHolbrook KerrSVP, Chief Commercial OfficerSSale−15.0K$11.00−$165.0K−15.2%83.9K after4 lots
Aug 15, 2025 (view filing)Aug 132 daysBlackford GaryDirectorPPurchase+20.0K$10.98+$219.6K+27.9%91.6K after
Aug 15, 2025 (view filing)Aug 132 daysBlackford GaryDirectorPPurchase+40.0K$11.00+$440.0KNew position40.0K after
Mar 10, 2025 (view filing)Mar 64 daysHolbrook KerrSVP, Chief Commercial OfficerSSale−7.00K$15.25−$106.8K−7.9%82.0K after
Mar 15, 2024 (view filing)Mar 141 dayGreiner MichaelSVP - Chief Financial OfficerSSale−8.00K$19.12−$153.0K−5.0%151.5K after6 lots
Mar 11, 2024 (view filing)Mar 11Same dayShimer Julie AnnDirectorPPurchase+500$19.85+$9.93K+1.0%50.1K after
Sep 16, 2021 (view filing)Sep 151 dayOleary Patrick JDirectorPPurchase+5.00K$31.63+$158.1K+17.3%33.9K after4 lots